These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7058686)

  • 21. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy.
    Soliman AM; Bonafede M; Farr AM; Castelli-Haley J; Winkel C
    J Manag Care Spec Pharm; 2016 May; 22(5):573-87. PubMed ID: 27123918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial histology and progesterone levels in women using norethindrone acetate implants for contraception.
    Takkar D; Jeyaseelan S; Kinra G; Laumas KR; Hingorani V
    Contraception; 1978 Feb; 17(2):103-13. PubMed ID: 630880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study.
    Gupta GN; Saxena BB; Landesman R; Ledger WJ
    Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma protein binding of norethisterone.
    Odlind V; Victor A; Johansson ED
    Contraception; 1982 May; 25(5):457-62. PubMed ID: 7201915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructure of human uterine epithelium at the time of implantation after postovulatory administration of norethindrone.
    Nilsson O; Nygren KG
    Ups J Med Sci; 1974; 79(2):65-71. PubMed ID: 4837833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
    Price TM; Dupuis RE; Carr BR; Stanczyk FZ; Lobo RA; Droegemueller W
    Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats.
    Daane TA; Dignam WJ; Frankland MV; Simmer HH; Parlow AF
    Am J Obstet Gynecol; 1973 Oct; 117(3):392-9. PubMed ID: 4729733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women.
    Bhatnagar S; Srivastava UK; Takkar D; Chandra VL; Hingorani V; Laumas KR
    Contraception; 1975 May; 11(5):505-21. PubMed ID: 1139938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; De La Pena A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Aug; 30(2):146-53. PubMed ID: 98357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.
    Eldon MA; Underwood BA; Randinitis EJ; Sedman AJ
    Neurology; 1998 Apr; 50(4):1146-8. PubMed ID: 9566412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal implants: contraception for a new century.
    Darney PD
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum levels and pharmacokinetics of norethisterone after ingestion of lynestrenol: its relation to dose and stage of the menstrual cycle.
    Kuhl H; Bremser HJ; Taubert HD
    Contraception; 1982 Sep; 26(3):303-15. PubMed ID: 7172676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Anovlar in gynaecological disorders and contraception.
    Shahani SM; Chiklikar A
    J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of biodegradable norethisterone implants as a 6-month contraceptive system.
    Rivera R; Gaitan JR; Ortega M; Flores C; Hernandez A
    Fertil Steril; 1984 Aug; 42(2):228-32. PubMed ID: 6745456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.